Trends in immune cell function assay and donor-specific HLA antibodies in kidney transplantation: A 3-year prospective study

American Journal of Transplantation

Volumn 13, Issue 12, 2013, Pages 3215-3222

  Libri, I ^a   Gnappi, E ^a   Zanelli, P ^a   Reina, M ^a   Giuliodori, S ^a   Vaglio, A ^a   Palmisano, A ^a   Buzio, C ^a   Riva, G ^b   Barozzi, P ^b   Luppi, M ^b   Cravedi, P ^c   Maggiore, U ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Anti HLA antibody; ImmuKnow; Kidney transplant

Indexed keywords

BASILIXIMAB; HLA ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ANTIBODY MEDIATED REJECTION; ARTICLE; CHRONIC GRAFT REJECTION; COLON PERFORATION; FEMALE; FOLLOW UP; GLOMERULOPATHY; GRAFT INFECTION; HUMAN; IMMUNE CELL FUNCTION ASSAY; IMMUNOASSAY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY TRACT INFECTION; VIRUS INFECTION;

ANTI-HLA ANTIBODY; IMMUKNOW; KIDNEY TRANSPLANT;

ADULT; ANTIBODIES; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVING DONORS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MONITORING, IMMUNOLOGIC; PANCREAS TRANSPLANTATION; PROSPECTIVE STUDIES; RISK;

EID: 84888312929     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12503     Document Type: Article

References (20)

1. United States Department of Health and Human Services. K013169; Cylex immune cell function assay, April 02, 2002.
2. Kowalski R, Post D, Schneider MC, et al. Immune cell function testing: An adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant 2003; 17: 77-88.
3. Kowalski RJ, Post DR, Mannon RB, et al. Assessing relative risks of infection and rejection: A meta-analysis using an immune function assay. Transplantation 2006; 82: 663-668.
4. Ling X, Xiong J, Liang W, et al. Can immune cell function assay identify patients at risk of infection or rejection? A meta-analysis. Transplantation 2012; 93: 737-743.
5. Sellares J, de Freitas DG, Mengel M, et al. Understanding the causes of kidney transplant failure: The dominant role of antibody-mediated rejection and nonadherence. Am J Transplant 2012; 12: 388-399.
6. Wiebe C, Gibson IW, Blydt-Hansen TD, et al. Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. Am J Transplant 2012; 12: 1157-1167.
7. Ginevri F, Nocera A, Comoli P, et al. Posttransplant de novo donor-specific HLA antibodies identify pediatric kidney recipients at risk for late antibody-mediated rejection. Am J Transplant 2012; 12: 3355-3362.
8. Stata longitudinal data/panel data reference manual release 12. College Station, TX: Stata Press, 2011.
9. Diggle PJ, Liang KY, Zeger SL., Marginal models, generalized estimating equation approach. In:, Atkinson AC, Copas JB, Pierce DA, Schervish MJ, Titterington DM, eds. Analysis of longitudinal data. Oxford: Oxford Science Publications, 1994, pp. 146-168.
10. DeLong ER, DeLong DM, Clarke-Pearson DL., Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 1988; 44: 837-845.
11. Altman DG, Machin D, Bryant TN, Gardner MJ., Diagnostic tests. In:, Altman DG, Machin D, Bryant TN, Gardner MJ, eds. Statistics with confidence. 2nd ed. Bristol: BMJ Publishing Group, 2000, pp. 105-110.
12. Bhorade SM, Janata K, Vigneswaran WT, Alex CG, Garrity ER., Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection. J Heart Lung Transplant 2008; 27: 990-994.
13. Kobashigawa JA, Kiyosaki KK, Patel JK, et al. Benefit of immune monitoring in heart transplant patients using ATP production in activated lymphocytes. J Heart Lung Transplant 2010; 29: 504-508.
14. Millan O, Sanchez-Fueyo A, Rimola A, et al. Is the intracellular ATP concentration of CD4+ T-cells a predictive biomarker of immune status in stable transplant recipients ? Transplantation 2009; 88: S78-S84.
15. Sanchez-Velasco P, Rodrigo E, Valero R, et al. Intracellular ATP concentrations of CD4 cells in kidney transplant patients with and without infection. Clin Transplant 2008; 22: 55-60.
16. Perez-Flores I, Sanchez-Fructuoso A, Santiago JL, et al. Intracellular ATP levels in CD4+ lymphocytes are a risk marker of rejection and infection in renal graft recipients. Transplant Proc 2009; 41: 2106-2108.
17. Huskey J, Gralla J, Wiseman AC., Single time point immune function assay (ImmuKnow) testing does not aid in the prediction of future opportunistic infections or acute rejection. Clin J Am Soc Nephrol 2011; 6: 423-429.
18. Serban G, Whittaker V, Fan J, et al. Significance of immune cell function monitoring in renal transplantation after Thymoglobulin induction therapy. Hum Immunol 2009; 70: 882-890.
19. Ruhil R, Bulut O, Telebagha S, et al. Viral determinants of pathogen induced alloantibody production. Am J Transplant 2013; 13 (Suppl 5, Abstract #D1453): 459.
20. Oh B, Ruhil R, Bulut O, et al. The effects of viral infection on chronic antibody-mediated rejection. Am J Transplant 2013; 13 (Suppl 5, Abstract #328): 132.